There are several dark clouds gathering over the stock market, but UBS warned this week that this overlooked situation “is the single biggest near term risk” to the market. Here’s what you need to know now.
Read MoreLooking for bargains? Traders say these 3 stocks look like opportunities now. Here’s why.
Read MoreBitcoin is sparking headlines again and has been surging higher on a wave of announcements that suggest wider acceptance of digital gold by financial mainstays.
Read MoreInvestors may be down on banking stocks, but one expert says there’s an opportunity with these 3 names in the sector.
Read MoreConsumer discretionary stocks have rallied this year amid the coronavirus pandemic, and traders and analysts see upside ahead for these 4 stocks in the sector.
Read MoreNew consoles means new customers and sales in the video game space, which is very good news for these 3 publishers.
Read MoreTrade Setup Stocks found in the category TradersPro New Uptrend are low priced stocks priced between .50 and $3, with at least 50k shares of average shares trading per day. The stocks are starting new uptrends and have buy signals. These are high reward to risk stocks with the potential for very sharp moves. A stop should […]
Read MoreTrade Setup Stocks found in the category TradersPro New Uptrend are low priced stocks priced between .50 and $3, with at least 50k shares of average shares trading per day. The stocks are starting new uptrends and have buy signals. These are high reward to risk stocks with the potential for very sharp moves. A stop should […]
Read MoreTrade Setup Buy Target $1.57 Sell Target $1.87 The stocks founds in the TradersPro Alerts category use a fixed entry and exit point using fibonacci analysis. It is a confirmation strategy that waits for the stock to make a move then a trader enters the trend at specific prices. The .382 fibonacci level of the prior trend […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MorePlus, weekly jobless claims fell to their lowest level since March, Moderna has officially enrolled 30,000 participants in its late-stage COVID-19 vaccine trial, and Tesla delivered an earnings beat.
Read MoreMarket commentary seems to have shifted a bit to focus on the political theater – both whether a second set of stimulus programs will be reached before the upcoming election, or speculation about the election itself. The unrelenting focus on COVID-19 vaccines up to now seems to have faded a bit, even though the pandemic […]
Read MoreBuy Price: $17.00 or better Sell Price: TradersPro Sell Signal Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics. It develops CDX-1140, an agonist human monoclonal antibody, which is being studied as a single-agent and in combination with CDX-301 in a Phase I dose-escalation study in […]
Read More